BIOMAT Database Logo BIOMAT Database Logo

Reappearance of tardive dystonia with olanzapine treated with clozapine. 2005

Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas

UI MeSH Term Description Entries
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004421 Dystonia An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77) Muscle Dystonia,Dystonia, Diurnal,Dystonia, Limb,Dystonia, Paroxysmal,Diurnal Dystonia,Dystonia, Muscle,Limb Dystonia,Paroxysmal Dystonia
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077152 Olanzapine A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,LY 170053,LY-170052,Olanzapine Pamoate,Zolafren,Zyprexa,LY 170052,LY170052
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D012563 Schizophrenia, Paranoid A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination. Delusional Disorder,Paranoid Schizophrenia,Delusional Disorders,Disorder, Delusional,Disorders, Delusional,Paranoid Schizophrenias,Schizophrenias, Paranoid

Related Publications

Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Tardive lingual dystonia treated with clozapine.
September 1996, Movement disorders : official journal of the Movement Disorder Society,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Olanzapine-induced tardive dystonia successfully treated by tetrabenazine.
January 2007, The Journal of neuropsychiatry and clinical neurosciences,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Reduction of tardive dystonia with olanzapine.
December 1999, The American journal of psychiatry,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Olanzapine induced tardive dystonia.
October 2008, Indian journal of pharmacology,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Olanzapine-induced tardive dystonia.
October 1999, The American journal of psychiatry,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Tardive dystonia associated with olanzapine therapy.
August 2001, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Clozapine and tardive dystonia.
February 1993, The Journal of nervous and mental disease,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Treatment of tardive pharyngolaryngeal dystonia with olanzapine.
February 2004, Schizophrenia research,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Successful treatment of tardive dystonia with clozapine.
June 1996, Biological psychiatry,
Isabel García-Lado, and Alejandro García-Caballero, and María José Recimil, and Ramón Area, and Guillermo Ozaita, and Santiago Lamas
Treatment of generalized tardive dystonia with clozapine.
September 2008, Psychiatria Danubina,
Copied contents to your clipboard!